Bafna Pharmaceuticals Ltd inaugurates new state-of-the-art QC Lab

Bafna Pharmaceuticals Ltd has announced the inauguration of a new State-of-the-Art Quality Control Laboratory ("QC Lab") at the company's manufacturing facility located at No. 147, Madhavaram Red Hills High Road, Grantlyon, Vadakarai, Chennai-600052, on April 26, 2024, marking a significant milestone for the company.

The new Quality Control Lab stands as a testament to its commitment to excellence, featuring sophisticated and cutting-edge technology designed to elevate the quality control processes to new heights. The QC Lab is equipped with advanced instruments to ensure rigorous quality control across all manufacturing processes. With this investment in state-of-the-art infrastructure, the company is confident that the products will consistently meet and exceed regulatory requirements and customer expectations.

Shares of Bafna Pharmaceuticals Limited was last trading in BSE at Rs. 87.81 as compared to the previous close of Rs. 86.94. The total number of shares traded during the day was 276 in over 9 trades.

The stock hit an intraday high of Rs. 87.84 and intraday low of 86.00. The net turnover during the day was Rs. 24089.00.

Source : Equity Bulls

Keywords

BafnaPharmaceuticals INE878I01022 QCLab Inauguration